Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2025 Earnings Call Transcript August 6, 2025
Operator: Good day, and thank you for standing by. Welcome to the Myriad Genetics Second Quarter 2025 Financial Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Matt Scalo. Please go ahead.
Matthew Scalo: Good afternoon, and welcome to the Myriad Genetics Second Quarter 2025...
